PhRMA applauds HCCU on health coverage

29 January 2007

The Pharmaceutical Research and Manufacturers of America (PhRMA) "commends Health Care Coverage for the Uninsured (HCCU) for addressing the important and serious problem of improving access to health coverage," said the association's president, Billy Tauzin, who added: "while we are still reviewing their plan, this much is clear: without access to such coverage, American families face a tremendous financial burden and too often go without the care and medicines they need."

Meantime, the PhRMA has debuted its 2007 national advertising campaign aimed at reaching those who lack health coverage and informing them of the assistance available through its Partnership for Prescription Assistance. Since April 2005, it says, the PPA has helped more than 3.2 million uninsured and low-income Americans find programs that provide prescription medicine gratis or nearly free. It also provides information on almost 10,000 free health care clinics

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight